PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-09-21

Date Title Company
21-Sep-2020 Asthma and COPD Drugs Market Study by Current and Upcoming Trends, Opportunities, Size, Trends and Forecast 2026 Wired Release
21-Sep-2020 Immune Regulation Limited Raises £40.6 Million / $53.4 Million Series B Equity Financing B3C newswire
21-Sep-2020 MagForce AG Publishes Shareholder Letter MagForce AG
21-Sep-2020 Global Point-of-Care Testing (POCT) Devices Market| Top Key players: Abbott, Alere, Roche, Siemens, Abaxis, and Acon Laboratories Lexis Business Insights
21-Sep-2020 Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners Relief Therapeutics Holdings AG
21-Sep-2020 Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners Relief Therapeutics & NeuroRx
21-Sep-2020 Global Monoclonal Mouse Antibody Market| Top Key players: Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, and Seattle Genetics Lexis Business Insights
21-Sep-2020 Latest report: Global Neuropathy Pain Treatment Market| Pfizer, Depomed, Eli Lilly, Endo, Grünenthal Group, and Arbor Pharmaceuticals Lexis Business Insights
21-Sep-2020 Latest report: Global Venous Stents Market|Boston Scientific, Medtronic, Veniti, Cook Medical, Optimed Med, and C.R. Bard Lexis Business Insights
21-Sep-2020 Hyde Engineering + Consulting Announces New VP of Global Engineering Hyde Engineering + Consulting, Inc.
21-Sep-2020 Hyde Engineering + Consulting Announces New VP of Global Engineering Hyde Engineering + Consulting, Inc.
21-Sep-2020 Key Milestone: The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain Shanghai SIMR Biotech Co.,Ltd
21-Sep-2020 Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020 Innovent Biologics, Inc.